Recombinant multi-species SYNCRIP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SYNCRIP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the cellular heterogeneous nuclear ribonucleoprotein (hnRNP) family. hnRNPs are RNA binding proteins that complex with heterogeneous nuclear RNA (hnRNA) and regulate alternative splicing, polyadenylation, and other aspects of mRNA metabolism and transport. The encoded protein plays a role in multiple aspects of mRNA maturation and is associated with several multiprotein complexes including the apoB RNA editing-complex and survival of motor neurons (SMN) complex. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the short arm of chromosome 20. [provided by RefSeq, Dec 2011]
The Alternative Names of target: 2610109K23Rik,4632417O19Rik,Ab2-339,GRY-RBP,GRYRBP,Glycine- and tyrosine-rich RNA-binding protein (GRY-RBP),HNRNPQ,HNRPQ1,Heterogeneous nuclear ribonucleoprotein Q,NS1-associated protein 1,NSAP1,Nsap1,Nsap1l,PP68,SYNCRIP,Synaptotagmin-binding,Syncrip,cytoplasmic RNA-interacting protein,hnRNP Q,hnRNP-Q,pp68

Target products collectionGo to SYNCRIP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP3546-Ag-1/ GM-Tg-hg-IP3546-Ag-2 Human SYNCRIP protein Human
GM-Tg-rg-IP3546-Ag-1/ GM-Tg-rg-IP3546-Ag-2 Rat SYNCRIP protein Rat
GM-Tg-mg-IP3546-Ag-1/ GM-Tg-mg-IP3546-Ag-2 Mouse SYNCRIP protein Mouse
GM-Tg-cynog-IP3546-Ag-1/ GM-Tg-cynog-IP3546-Ag-2 Cynomolgus/Rhesus macaque SYNCRIP protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP3546-Ag-1/ GM-Tg-felg-IP3546-Ag-2 Feline SYNCRIP protein Feline
GM-Tg-cang-IP3546-Ag-1/ GM-Tg-cang-IP3546-Ag-2 Canine SYNCRIP protein Canine
GM-Tg-bovg-IP3546-Ag-1/ GM-Tg-bovg-IP3546-Ag-2 Bovine SYNCRIP protein Bovine
GM-Tg-equg-IP3546-Ag-1/ GM-Tg-equg-IP3546-Ag-2 Equine SYNCRIP protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP3546-Ag-1/ GM-Tg-hg-IP3546-Ag-2; GM-Tg-rg-IP3546-Ag-1/ GM-Tg-rg-IP3546-Ag-2;
GM-Tg-mg-IP3546-Ag-1/ GM-Tg-mg-IP3546-Ag-2; GM-Tg-cynog-IP3546-Ag-1/ GM-Tg-cynog-IP3546-Ag-2;
GM-Tg-felg-IP3546-Ag-1/ GM-Tg-felg-IP3546-Ag-2; GM-Tg-cang-IP3546-Ag-1/ GM-Tg-cang-IP3546-Ag-2;
GM-Tg-bovg-IP3546-Ag-1/ GM-Tg-bovg-IP3546-Ag-2; GM-Tg-equg-IP3546-Ag-1/ GM-Tg-equg-IP3546-Ag-2
Products Name SYNCRIP protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SYNCRIP
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SYNCRIP protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.